Enhanced Immune Response with Stabilized Norovirus Virus-Like Particles (VLPs): A Next-Generation Vaccine Approach

National Institute of Allergy and Infectious Diseases sent this bulletin at 03/12/2024 03:11 PM EDT

3D print of Norwalk virus, a type of norovirus Credit: NIH

Researchers at NIAID have created a novel approach to develop vaccines targeting norovirus. This technology uses improved VLPs that are engineered for greater stability and potency. The new VLPs may improve the effectiveness of vaccines against norovirus, particularly in individuals with previously low response rates to traditional vaccines. This technology could also be used to develop effective vaccines against a wide range of pathogens and may be suitable for broad-scale immunization programs.

Read more about this exciting collaboration opportunity at https://go.nih.gov/6vbTbzs or contact Brian Bailey, Ph.D. at 240-669-5128, 301-201-9217, or bbailey@mail.nih.gov and reference E-178-2019.

#NIAID #NIH #Norovirus

Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help.

This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).